- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01751542
Mindfulness and Acceptance Group Therapy for Substance Use
December 13, 2012 updated by: The University of Tennessee, Knoxville
Randomized clinical trial comparing standard residential substance abuse treatment to standard residential treatment plus Mindfulness and Acceptance Group Therapy for substance use.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37996
- Recruiting
- University of Tenneessee & Cornerstone of Recovery
-
Contact:
- Gregory Stuart, PhD
- Phone Number: 865-974-3358
-
Principal Investigator:
- Gregory L Stuart, PhD
-
Principal Investigator:
- Ryan Shorey, MA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- participating in inpatient substance use treatment at treatment facility
Exclusion Criteria:
- psychosis and mental impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness + residential treatment
Mindfulness and Acceptance Group Therapy + residential treatment
|
|
|
Active Comparator: Residential Treatment
Residential treatment alone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Substance use after discharge from treatment
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Anticipated)
December 1, 2013
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
December 13, 2012
First Submitted That Met QC Criteria
December 13, 2012
First Posted (Estimate)
December 18, 2012
Study Record Updates
Last Update Posted (Estimate)
December 18, 2012
Last Update Submitted That Met QC Criteria
December 13, 2012
Last Verified
December 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8888-B
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorder
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)CompletedSubstance Use Disorder | Opioid Use Disorder | Heroin Use DisorderUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of Wisconsin, MadisonRevive Therapeutics, Ltd.TerminatedSubstance-Related Disorders | Chemically-Induced Disorders | Substance Use Disorders | Methamphetamine Use Disorder | Stimulant-Use DisorderUnited States
Clinical Trials on Mindfulness + Residential Treatment
-
VA Office of Research and DevelopmentVA Boston Healthcare System; Center for Biostatistics and Health Data ScienceCompletedPTSD | Substance Use DisordersUnited States
-
Ohio State UniversityCompletedParenting | Mental Disorder in Adolescence | Adolescent - Emotional ProblemUnited States
-
New York UniversityCompletedSubstance Use DisordersUnited States
-
University of MiamiCompletedSubstance Use | DelinquencyUnited States
-
Holland Bloorview Kids Rehabilitation HospitalMcMaster Children's Hospital; ErinoakKids Centre for Treatment and DevelopmentCompletedChild-onset DisabilityCanada
-
University of Texas Southwestern Medical CenterTerminatedType1diabetesUnited States
-
Lund UniversityCompleted
-
Lauro Gutiérrez CastroRecruitingAnxiety | Addiction | Emotional Dysregulation | Rumination - Thoughts | Substance Use Disorder (SUD)Mexico
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...RecruitingMigraine | Migraine Disease | High Frequency Episodic MigraineItaly
-
Illinois Institute of TechnologyElevateCompletedAsthma | Pollution; ExposureUnited States